Home > Products > CEA & GD2 > Anti-CEA x Anti-GD2 Bispecific Antibody (IgG-IgG)

Anti-CEA x Anti-GD2 Bispecific Antibody (IgG-IgG)  (BSIG-138)

Anti-CEA x Anti-GD2 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CEA and anti-GD2 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind two factors simultaneously. It is designed for the research of Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors therapy.

Specifications

Targets
CEA & GD2
Type
IgG-IgG
Species Reactivity
Human
Target 1
CEA
Host Animal 1
Mouse
Target 2
GD2
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
Neuroblastoma; Osteosarcoma; Melanoma; Solid tumors

Targets

Target 1
CEA
Gene ID
UniProt ID
Alternative Names
CEACAM5; carcinoembryonic antigen; carcinoembryonic antigen related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100
Target 2
GD2
Alternative Names
Ganglioside GD2; GD2; Ganglioside; Disialoganglioside GD2

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-CEA x Anti-GD2 Bispecific Antibody (IgG-IgG) (BSIG-138). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CEA & GD2"
Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: